Filana Therapeutics, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $46.4M
- Price
- $0.961
- % Change (Daily % change from the live per-ticker quote feed.)
- +1.96%
- Volume
- 107.6K
About
Filana Therapeutics, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.
Quick stats
Shares outstanding48.3M
Computed float45.6M
Float / shares94.4%
Key info
SectorHealthcare
IndustryBiotechnology
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001069530
Websitehttps://www.filanatx.com
AI Summary
AI-generated1/5
minorneutrallegal litigation
Did Filana Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Halper Sadeh LLC issued a solicitation notice investigating whether officers and directors of Filana Therapeutics breached their fiduciary duties to shareholders.
The firm is encouraging long-term shareholders to contact them to discuss potential corporate governance reforms or financial incentive awards on a contingent fee basis.
This is an investor rights law firm marketing announcement and not an admission of liability or an official filing by the company itself.